findmyKOL
Clinical trialNCT00737243CompletedPhase 2Interventional

Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site

SponsorSCRI Development Innovations, LLCEnrollment289Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Oncology Specialties (clearview Cancer Institute)

    Huntsville, Alabama, United States

  • Florida Cancer Specialists

    Fort Myers, Florida, United States

  • Integrated Community Oncology Network

    Jacksonville, Florida, United States

  • Watson Clinic Center for Cancer Care and Research

    Lakeland, Florida, United States

  • Florida Hospital Cancer Institute

    Orlando, Florida, United States

  • Northeast Georgia Medical Center

    Gainesville, Georgia, United States

  • Wellstar Cancer Research

    Marietta, Georgia, United States

  • Oncology Hematology Associates of Sw Indiana

    Evansville, Indiana, United States

  • Baptist Hospital East

    Louisville, Kentucky, United States

  • Hematology Oncology Clinic, Llp

    Baton Rouge, Louisiana, United States

  • Center for Cancer and Blood Disorders

    Bethesda, Maryland, United States

  • Grand Rapids Clinical Oncology Program

    Grand Rapids, Michigan, United States

  • Jackson Oncology Associates

    Jackson, Mississippi, United States

  • Nebraska Methodist Cancer Center

    Omaha, Nebraska, United States

  • Hematology Oncology Associates of Northern Nj

    Morristown, New Jersey, United States

  • Oncology Hematology Care

    Cincinnati, Ohio, United States

  • Spartanburg Regional Medical Center

    Spartanburg, South Carolina, United States

  • Chattanooga Oncology Hematology Associates

    Chattanooga, Tennessee, United States

  • Tennessee Oncology, Pllc

    Nashville, Tennessee, United States

  • Center for Cancer and Blood Disorders

    Fort Worth, Texas, United States

  • Virginia Cancer Institute

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2008
Primary completion
30 Nov 2012
Completion
31 Dec 2012
Last update posted
17 Aug 2016
Registered enrollment
289
Registry id
NCT00737243

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.